Tag Archives: firm

Monday’s sinking stocks and the reasons why (CBRX, RIMM, TWIN)

Posted on January 23, 2012 by Martin Timble

In this report: Columbia Laboratories (NASDAQ:CBRX), Research in Motion (NASDAQ:RIMM) and Twin Disc (NASDAQ:TWIN).

Columbia Laboratories (NASDAQ:CBRX) has tanked by more than 58 percent today after an advisory panel of the Food and Drug Administration voted against the approval of …

Posted in Latest Headlines, Reports | Tagged CBRX, CEO, Columbia Laboratories, Deutsche Bank, earnings, FDA, financials, firm, Food and Drug Administration, Jim Balsillie, Mike Lazardis, NASDAQ, NASDAQ:CBRX, NASDAQ:RIMM, NASDAQ:TWIN, oil and gas, progesterone, quarter, rating, report, Research in Motion, revenue, RIMM, TWIN, Twin Disc, upgrade | Comments Off

What the fuss Sirius XM Radio, Entergy and PetMed Express?

Posted on January 23, 2012 by Martin Timble

In this report: Sirius XM Radio (NASDAQ:SIRI), Entergy Corporation (NYSE:ETR), PetMed Express (NASDAQ:PETS).

Sirius XM Radio (NASDAQ:SIRI) is trading a percent lower today after the company received a downgrade by analysts at Morgan Stanley. The firm cut its rating to …

Posted in Latest Headlines, Reports | Tagged analyst, commodities, company, downgrade, earnings, Entergy Corporation, ETR, expectations, financials, firm, Morgan Stanley, NASDAQ, NASDAQ:PETS, NASDAQ:SIRI, NYSE, NYSE:ETR, PetMed Express, pets, rating, report, revenue, share, SIRI, Sirius XM Radio, trading, Wall Street | Comments Off

Big time losers and the reasons why (KUTV, COOL, GEN)

Posted on January 18, 2012 by Martin Timble

In this report: Ku6 Media (NASDAQ:KUTV), Majesco Entertainment Company (NASDAQ:COOL) and GenOn Energy (NYSE:GEN).

Ku6 Media (NASDAQ:KUTV) shares are seeing a correction today after rallying by more than 136 percent on Tuesday. The surge came after the company announced that …

Posted in Latest Headlines, Reports | Tagged adjusted, Analysts, Coal, company, COOL, costs, CSAPR, downgrade, firm, fiscal, forecast, GEN, GenOn Energy, Google, Ku6 Media, KUTV, Majesco Entertainment Company, NASDAQ, NASDAQ:COOL, NASDAQ:KUTV, NYSE, NYSE:GEN, operating, price target, profit, quarter, report, results, revenue, sell, shares, UBS, youtube | Comments Off

Tuesday’s mixed bag of stocks (CLDX, AKRX, AMAT)

Posted on January 17, 2012 by Cameron White

In this report: Celldex Therapeutics (NASDAQ:CLDX), Akorn (NASDAQ:AKRX) and Applied Materials (NASDAQ:AMAT).

Celldex Therapeutics (NASDAQ:CLDX) gained more than 17 percent on Tuesday after the company announced the initiation of it Phase 1 clinical trial of its hematopoietic growth factor, CDX-301. …

Posted in Latest Headlines, Main Post | Tagged Akorn, AKRX, AMAT, analyst, Applied Materials, Buy, Celldex Therapeutics, CLDX, company, develop, earn, expectations, firm, fiscal, growth, NASDAQ, NASDAQ:AKRX, NASDAQ:AMAT, NASDAQ:CLDX, price target, profit, rating, RBC Capital, revenue, Roth Capital, share, tech, upgrade | Comments Off

Soaring stocks and the reasons why (RIMM, WYNN, ARQL)

Posted on January 17, 2012 by Martin Timble

In this report: Research in Motion (NASDAQ:RIMM), Wynn Resorts (NASDAQ:WYNN) and ArQule (NASDAQ:ARQL).

Research in Motion (NASDAQ:RIMM) is trading over 9 percent higher today on speculation that the company could be the target of a takeover by Samsung. The specuation …

Posted in Latest Headlines, Reports | Tagged ARQL, ArQule, BGR, casino operator, chona, company, firm, GDP, growth, Jim Balsillie, Jonathan Geller, NASDAQ, NASDAQ:ARQL, NASDAQ:RIMM, NASDAQ:WYNN, phase 2 clinical trial, Research in Motion, RIM, RIMM, samsung, speculation, Susquehanna, takeover, Target, tivantinib, trading, treatment, WYNN, Wynn Resorts | Comments Off

What the fuss Ista Pharmaceuticals, Yingli Energy and Potash Corp.?

Posted on January 17, 2012 by Josie Middleton

In this report: Yingli Green Energy Holding (NYSE:YGE), ISTA Pharmaceuticals (NASDAQ:ISTA) and Potash Corp. of Saskatchewan (NYSE:POT).

ISTA Pharmaceuticals (NASDAQ:ISTA) is trading over 11 percent higher today after Valeant Pharmaceuticals International raised its offer for the company by a dollar …

Posted in Latest Headlines, Reports | Tagged aaron chew, analyst, CIBC World Markets, demand, firm, forecast, ISTA, ISTA Pharmaceuticals, maixm group, NASDAQ, NASDAQ:ISTA, NYSE, NYSE:POT, NYSE:YGE, offer, POT, Potash Corp. of Saskatchewan, quarter, rating, sector, solar stock, stock, trading, upgraded, Valeant, YGA, Yingli Green Energy Holding | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.